The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making
- PMID: 33764395
- DOI: 10.1001/jamaoncol.2021.0122
The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making
Comment in
-
The Role of Acute Myeloid Leukemia Minimal Residual Disease in Regulatory Decision-making-Reply.JAMA Oncol. 2021 May 1;7(5):784-785. doi: 10.1001/jamaoncol.2021.0128. JAMA Oncol. 2021. PMID: 33764393 No abstract available.
Comment on
-
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.JAMA Oncol. 2020 Dec 1;6(12):1890-1899. doi: 10.1001/jamaoncol.2020.4600. JAMA Oncol. 2020. PMID: 33030517 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical